Growing mortality rates arising out of surging gastrointestinal infections, including diarrhea, is prompting governments to fund drug and vaccine development programs to mitigate this global burden
Analgesic norovirus treatment drugs will continue to witness growing preference among healthcare providers, according to latest findings by consulting firm Fact.MR. In a new study on global norovirus treatment market, sales are likely to witness gains in 2021 as effective gastrointestinal treatment becomes key focus area. The report opines an optimistic outlook on the norovirus treatment market for the future.
Request Sample at – https://www.factmr.com/connectus/sample?flag=S&rep_id=2696
The growing incidences of norovirus infection are expected to drive the growth of the norovirus treatment market over the forecast period. Changes in lifestyle and eating habits such as intake of more junk food and less intake of water, are expected to drive the norovirus treatment market.
Lack of awareness about contamination through personal items can increase the growth of the norovirus treatment market. Norovirus treatment by using homemade remedies can restrain the growth of the norovirus treatment market.
“Manufacturers are accelerating their research and development capacities to dole out potential drug and vaccine candidates in the future. Current dearth of any direct approach to eradicating the virus is widening expansion prospects, thereby widening the revenue prospects for key players operating within the market,” says the Fact.MR analyst.
Key Takeaways
- Analgesic norovirus treatment drugs to acquire surging popularity, attributed to easy over-the-counter availability
- Retail pharmacies will record highest sales of norovirus treatment medicines
- US sales will account for significant share of global reveues
- Breakthroughs in treatment procedures to accelerate growth prospects across the UK
- Germany and France to emerge as highly lucrative markets, fueled by increasing investments in stomach infection treatments
- India and China to generate potential revenue ecosystems in the forthcoming decade
Norovirus Treatment Market: Segmentation
Tentatively, the global norovirus treatment market can be segmented on the basis of product type, indication, application, end user, and geography.
Based on product type, the global norovirus treatment market is segmented as:
- Electrolytes
- Intravenous Fluids
- Antipyretics
- Analgesics
Based on end user, the global norovirus treatment market is segmented as:
-
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Prominent Drivers
- Increased consumption of contaminated food and water is increasing norovirus infection incidences, bolstering treatment prospects
- Manufacturers are finding increased opportunities in development of antiviral fluids
- Fast-track governmental approvals of key drug candidates to bolster future sales of norovirus treatment drugs
Discover more about the ultrasonic scalpels market with figures, data tables and the table of contents. You will also find detailed market segmentation on https://www.factmr.com/report/2696/norovirus-treatment-market
Key Restraints
- Increased frequency of product recalls amid perceived ineffectiveness to hamper sales
- Expensive diagnostics for the infection discourages patients across developing economies to desist from seeking treatment, thus limiting penetration
Competitive Landscape
Prominent companies include NIMRAJ CHEM AGROVET, Meda Pharmaceuticals Inc., Mizuno Pharmacies and Valeant Pharmaceuticals International Inc. (Bausch Health). The market is highly fragmented, leading to heightened competition levels. Therefore, a variety of expansion strategies are being deployed by the aforementioned market players.
In February 2021, Bausch Health Companies’ Salix Pharmaceuticals announced the opening of the application period for the 2021 Salix Gastrointestinal Health Scholars Program. The program is expected to award 10 outstanding students living with a GI disease a scholarship of up to US$ 10,000 to help them pursue higher education goals.
More Insights on the Norovirus Treatment Market
In its latest report, Fact.MR offers unbiased analysis of the global norovirus treatment market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product (electrolytes, intravenous fluids, antipyretics & analgesics) and end users (hospital pharmacies, online pharmacies & retail pharmacies) across seven major regions (North America, APEJ, Japan, Western Europe, Eastern Europe, Latin America and Middle East & Africa).
Read More Trending and Similar Reports from Fact.MR – https://www.biospace.com/article/titles-surge-in-research-and-development-activities-boosts-global-cell-lines-market/
Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:
Fluoro Enzymatic Assays Market – https://www.factmr.com/report/fluoro-enzymatic-assays-market
Shower Chairs Market – https://www.factmr.com/report/shower-chairs-market
Infrared Thermometer Market – https://www.factmr.com/report/infrared-thermometer-market
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
4-1-1 Nakano,
9F Nakano Sunplaza
Tokyo, 164-8512
Japan
Tel: +1 (888) 863-5616
E-Mail: sales@factmr.com
